Folfiri-aflibercept vs folfiri-bevacizumab as second line treatment of RAS mutated metastatic colorectal cancer in real practice

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 29 Suppl 8; p. viii160
Main Authors: Ottaiano, A, Capozzi, M, De Divitiis, C, Cassata, A, De Stefano, A, Tafuto, S, Avallone, A, Nasti, G
Format: Journal Article
Language:English
Published: England 01-10-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Author Cassata, A
Avallone, A
Ottaiano, A
Tafuto, S
Nasti, G
De Divitiis, C
Capozzi, M
De Stefano, A
Author_xml – sequence: 1
  givenname: A
  surname: Ottaiano
  fullname: Ottaiano, A
  organization: SSD Innovative Therapies for Abdominal Metastases - Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy
– sequence: 2
  givenname: M
  surname: Capozzi
  fullname: Capozzi, M
  organization: Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy
– sequence: 3
  givenname: C
  surname: De Divitiis
  fullname: De Divitiis, C
  organization: Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy
– sequence: 4
  givenname: A
  surname: Cassata
  fullname: Cassata, A
  organization: Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy
– sequence: 5
  givenname: A
  surname: De Stefano
  fullname: De Stefano, A
  organization: Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy
– sequence: 6
  givenname: S
  surname: Tafuto
  fullname: Tafuto, S
  organization: Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy
– sequence: 7
  givenname: A
  surname: Avallone
  fullname: Avallone, A
  organization: Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy
– sequence: 8
  givenname: G
  surname: Nasti
  fullname: Nasti, G
  organization: SSD Innovative Therapies for Abdominal Metastases - Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32136276$$D View this record in MEDLINE/PubMed
BookMark eNo9kMtKxDAUhoOMOBd9ADeSF-iYNG2aLIfBUWFA8LIu6ckJRHoj6QyMKx_dSkdX_-HnfP_iW5JZ27VIyC1na860uDftWMB9Y0-p4muW5hdkwXOpE8UyPiMLplORFLnI5mQZ4ydjTOpUX5G5SLmQaSEX5HvX1c4HnxhX-woDYD_QY6TuXFd4NOC_Do2pqIk0InStpbVvkQ4BzdBgO9DO0dfNG20OgxnQ0gYHE8fTA4Wu7gLCYGoKpgUM1Ld05GraBwPjB16TS2fqiDfnXJGP3cP79inZvzw-bzf7BHih8sTlDDIFTEmFKkewTKoiBYW504ynWldW6KoymTHa5pmTGfKKYYHWFVJlQqwIn3YhdDEGdGUffGPCqeSs_LVZTjbLyWY52hyZu4npD1WD9p_40yd-AISmd7w
ContentType Journal Article
DBID NPM
AAYXX
CITATION
DOI 10.1093/annonc/mdy281.025
DatabaseName PubMed
CrossRef
DatabaseTitle PubMed
CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1569-8041
ExternalDocumentID 10_1093_annonc_mdy281_025
32136276
Genre Journal Article
GroupedDBID ---
-E4
.2P
.86
.I3
.XZ
.ZR
08P
0R~
0SF
0U7
1TH
23M
2WC
4.4
482
48X
53G
5GY
5VS
5WA
6.Y
6J9
70D
AAEDW
AAJKP
AAJQQ
AAKAS
AAKUH
AALRI
AAMVS
AAOGV
AAPNW
AAUQX
AAXUO
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNKS
ABOCM
ABQLI
ABQTQ
ABSAR
ABSMQ
ABVKL
ABZBJ
ACGFO
ACGFS
ACMRT
ACPQN
ACPRK
ACUFI
ACUTO
ADBBV
ADEYI
ADHKW
ADHZD
ADJQC
ADOCK
ADRIX
ADRTK
ADVLN
ADYVW
ADZCM
ADZXQ
AEGPL
AEGXH
AEHUL
AEJOX
AEKPW
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AEWNT
AFETI
AFIYH
AFJKZ
AFOFC
AFSHK
AFXEN
AGINJ
AGKEF
AGKRT
AGSYK
AHMBA
AHXPO
AIAGR
AIJHB
AITUG
AKRWK
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AMRAJ
APIBT
APWMN
AQKUS
ASPBG
ATTQO
AVWKF
AXUDD
AZFZN
BAWUL
BAYMD
BGNMA
BHONS
BTRTY
BVRKM
BZKNY
C1A
CAG
CDBKE
CKLRP
COF
CS3
CZ4
DAKXR
DIK
DILTD
DL5
D~K
E3Z
EBS
EE~
EJD
EX3
F9B
FDB
FEDTE
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
I09
IH2
IHE
IOX
J21
KAQDR
KDC
KOM
KOP
KQ8
KSI
KSN
LAK
M-Z
M41
M49
M4Y
MBLQV
MHKGH
N9A
NCXOZ
NGC
NOYVH
NPM
NTWIH
NU-
NU0
NVLIB
O9-
OAWHX
ODMLO
OJQWA
OK1
OVD
P2P
P6G
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RNI
ROL
ROX
ROZ
RPX
RW1
RXO
RZC
RZE
RZF
RZO
SDH
TCURE
TEORI
TJX
TMA
TR2
U2A
W8F
WOQ
WOW
X7H
YAYTL
YFH
YKOAZ
ZKX
ZXP
~91
AAYXX
CITATION
ID FETCH-LOGICAL-c1785-f50c48c0868e85ecd06872c8e5f901299bd39bba4aa9d54f64e1b0e7edf768433
ISSN 0923-7534
IngestDate Thu Nov 21 20:48:42 EST 2024
Wed Oct 16 00:46:54 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1785-f50c48c0868e85ecd06872c8e5f901299bd39bba4aa9d54f64e1b0e7edf768433
OpenAccessLink https://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy281.025/26139692/mdy281.025.pdf
PMID 32136276
ParticipantIDs crossref_primary_10_1093_annonc_mdy281_025
pubmed_primary_32136276
PublicationCentury 2000
PublicationDate 2018-Oct
2018-10-00
PublicationDateYYYYMMDD 2018-10-01
PublicationDate_xml – month: 10
  year: 2018
  text: 2018-Oct
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Annals of oncology
PublicationTitleAlternate Ann Oncol
PublicationYear 2018
SSID ssj0006929
Score 2.31483
SourceID crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage viii160
Title Folfiri-aflibercept vs folfiri-bevacizumab as second line treatment of RAS mutated metastatic colorectal cancer in real practice
URI https://www.ncbi.nlm.nih.gov/pubmed/32136276
Volume 29 Suppl 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9wwEBabFEIupe8mfaBDTzUmfsmPY0g2pJS2h6TQm5H1AEHXXtZeQ_fUn54Zy491m0J76MUYWbaxvo_RjDzziZB3gnkhEyJxlQ4xQPEit-CBgpjH137hy4x3SF_fJJ-_pZfLaLlYDFIVU9t_RRraAGusnP0HtMeHQgOcA-ZwBNTh-Fe4X1XftdkYl-sucwSzVpwWRRdsc6FaLsxuu-IFbjFTYzwsnc7XnHLOUaDk_MZZbdETlbjLNMfCIyMc1LhGG4mqIsiXja2HwXKuvtxq39ud1JmrUszW7780DQdiVrPV1Au-rnY7M1ujvVRglVvTmF4LYepb17zh0_39yoWfjjlwMPH01jbOXBRA2jfHQeZ0G5o66Z5dbY0xvt144Debb_WweFnCp8DJSv4IUhRiZfu9AaT1qoM8DHyYtJNf9LftjN5fOiAPArBbXYT-4eM4scfgSg4_xrPwzL7xbHrfMTkanjDzcmbxSue33D4iD_uAg55bpjwmC1U-IUef-pSKp-TnPYShbU3vIQzlNbWEoUgYOhKGVpoCYWhPGDoRhk6EoZYw1JQUCUMHwjwjX6-WtxfXbr8thyv8JGWuZp6IUgGxcKpSpoT04jQJRKqYznBZMytkmBUFjzjPJIt0HCm_8FSipMa_vmH4nBzCyKmXhOo4VIypJIPgKYqConPBiyDR2pehkvKEvB-GMV9b9ZXcZk2EuR3-3A5_DvedkBd2oMeuAxqnf7zyihxPzHxNDpvNVr0hB7Xcvu2wvwNvEYNf
link.rule.ids 315,782,786,27933,27934
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Folfiri-aflibercept+vs+folfiri-bevacizumab+as+second+line+treatment+of+RAS+mutated+metastatic+colorectal+cancer+in+real+practice&rft.jtitle=Annals+of+oncology&rft.au=Ottaiano%2C+A&rft.au=Capozzi%2C+M&rft.au=De+Divitiis%2C+C&rft.au=Cassata%2C+A&rft.date=2018-10-01&rft.eissn=1569-8041&rft.volume=29+Suppl+8&rft.spage=viii160&rft_id=info:doi/10.1093%2Fannonc%2Fmdy281.025&rft_id=info%3Apmid%2F32136276&rft.externalDocID=32136276
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon